• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Effect of drug intake prior to or after meals on serum theophylline concentrations: single-dose studies with Euphylong.

作者信息

Schulz H U, Karlsson S, Sahner-Ahrens I, Steinijans V W, Beier W

出版信息

Int J Clin Pharmacol Ther Toxicol. 1987 Apr;25(4):222-8.

PMID:3583472
Abstract

Three separate single-dose, randomized, cross-over studies in normal, healthy volunteers were performed to investigate the possible influence of drug intake in relation to concomitant food intake and of different dietary habits such as cold and hot evening meals on the bioavailability of theophylline from Euphylong. Euphylong is a new, pH- and rpm-independent theophylline formulation designed for once-daily administration in the evening. The results obtained show that the timing of drug intake, in relation to concomitant food intake, has no influence on the bioavailability of Euphylong. Under equicaloric conditions, a 10% decrease in AUC and a 20% decrease in Cmax is observed when Euphylong is administered after a hot evening meal compared with a cold evening meal. Viewed against the dramatic changes in bioavailability of up to 100%, which have been observed for certain other sustained-release theophylline formulations, these minor changes for Euphylong are negligible and without clinical relevance.

摘要

相似文献

1
Effect of drug intake prior to or after meals on serum theophylline concentrations: single-dose studies with Euphylong.
Int J Clin Pharmacol Ther Toxicol. 1987 Apr;25(4):222-8.
2
Pharmacokinetic profile of a new sustained-release theophylline pellet formulation for once-daily evening administration.一种用于每日一次晚间给药的新型缓释茶碱微丸制剂的药代动力学特征。
Arzneimittelforschung. 1988 Aug;38(8A):1241-50.
3
Evaluation of the effect of 3 different diets on the bioavailability of 2 sustained release theophylline matrix tablets.评估3种不同饮食对2种缓释茶碱基质片生物利用度的影响。
Int J Clin Pharmacol Ther. 1997 Dec;35(12):565-71.
4
Study on the influence of food on the absorption of theophylline from a controlled-release preparation.
Arzneimittelforschung. 1994 Mar;44(3):333-7.
5
Once daily theophylline: multiple-dose comparison of an encapsulated micro-osmotic system (Euphylong) with a tablet (Uniphyllin).每日一次的茶碱:一种胶囊型微渗透系统(优菲龙)与片剂(优喘平)的多剂量比较。
Int J Clin Pharmacol Ther Toxicol. 1986 Aug;24(8):438-47.
6
Influence of food on the bioavailability of theophylline from a sustained-released theophylline preparation.食物对缓释型茶碱制剂中茶碱生物利用度的影响。
Arzneimittelforschung. 1991 Jul;41(7):732-4.
7
Steady-state pharmacokinetics of a once-daily theophylline formulation (Euphylong) when given twice daily.
Int J Clin Pharmacol Ther. 1994 Apr;32(4):168-73.
8
Effect of meals and dosage-form modification on theophylline bioavailability from a 24-hour sustained-release delivery system.进餐和剂型改变对茶碱从24小时缓释给药系统中生物利用度的影响。
Clin Ther. 1994 Sep-Oct;16(5):804-14.
9
[24-hour lung function in asthmatic patients: chrono-optimal theophylline therapy as once-daily Euphylong administration vs conventional twice-daily administration].
Pneumologie. 1991 Nov;45 Suppl 4:834-41.
10
Comparison of aminophylline and theophylline sustained-release formulations by their bioavailability and steady-state serum levels.
Int J Clin Pharmacol Ther Toxicol. 1983 Dec;21(12):624-30.

引用本文的文献

1
Influence of endogenous and exogenous effectors on the pharmacokinetics of theophylline. Focus on biotransformation.内源性和外源性效应物对茶碱药代动力学的影响。重点关注生物转化。
Clin Pharmacokinet. 1995 Apr;28(4):287-314. doi: 10.2165/00003088-199528040-00003.
2
Food interactions with sustained-release theophylline preparations. A review.食物与缓释茶碱制剂的相互作用。综述。
Clin Pharmacokinet. 1989 Mar;16(3):162-79. doi: 10.2165/00003088-198916030-00003.
3
Controversies in bioequivalence studies.生物等效性研究中的争议
Clin Pharmacokinet. 1992 Apr;22(4):247-53. doi: 10.2165/00003088-199222040-00001.